Clinical Trials Logo

Clinical Trial Summary

The purpose of this First In Human study is to investigate the safety and tolerability of KL1333 after a single oral dose and to investigate the pharmacokinetic characteristics of KL1333 after a single oral dose.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03056209
Study type Interventional
Source Yungjin Pharm. Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date June 26, 2017
Completion date April 16, 2018

See also
  Status Clinical Trial Phase
Completed NCT01831934 - Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS) Phase 4
Not yet recruiting NCT06013397 - Effectiveness of Ketogenic Diet in MELAS Syndrome N/A
Completed NCT04165239 - The KHENERGYZE Study Phase 2
Completed NCT01603446 - L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome Phase 2
Completed NCT00887562 - Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes Phase 2
Active, not recruiting NCT00068913 - Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome Phase 2
Completed NCT03888716 - A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease Phase 1
Completed NCT04948138 - Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome N/A
Completed NCT01339494 - Nitric Oxide Production in MELAS Syndrome Phase 0
Active, not recruiting NCT05255328 - Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome N/A
Recruiting NCT02114554 - Mitochondrial nt3243 A>G Mutation in Taiwan N/A
Recruiting NCT05554835 - Global Registry and Natural History Study for Mitochondrial Disorders
Completed NCT01252979 - Ketones & Mitochondrial Heteroplasmy Phase 0
Completed NCT00004353 - Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia N/A
Recruiting NCT03952234 - L-Citrulline Dose Finding Safety Study in MELAS Phase 1